This vaccine helps protect against a serious infection called invasive meningococcal disease, caused by group B meningococcal bacteria. This infection can cause meningitis (swelling around the brain and spinal cord) or a serious bloodstream infection, and can become severe very quickly.
TRUMENBA is listed under Health Canada DIN 02468751. The product record and monograph below describe this formulation; the dose schedule comes from the Canadian Immunization Guide.
At a glance
Brand
TRUMENBA
DIN
02468751
Vaccine
Meningococcal group B (MenB-fHBP)
Presentation
60 mcg / 0.5 mL · suspension · intramuscular · 10 years and older
Live vaccine
No
Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with a healthcare professional.
Official sources
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
A listed product may not be stocked or publicly funded.
Before and after your vaccination
Bring your immunization record if you have one, so earlier doses can be checked.
Tell the healthcare professional about a serious reaction to a previous vaccine or an ingredient, and mention any health conditions or medicines that could affect your vaccination.
After the dose, stay where you can be observed for at least 15 minutes. Tell someone right away if you feel faint or develop symptoms of an allergic reaction.
Keep a record of the vaccine name, date and dose you received.
The details below are adapted from a Pharmasist patient handout linked to the same product monograph. The current Canadian Immunization Guide determines the dose schedules shown later.
What this vaccine helps prevent
This vaccine helps protect against a serious infection called invasive meningococcal disease, caused by group B meningococcal bacteria. This infection can cause meningitis (swelling around the brain and spinal cord) or a serious bloodstream infection, and can become severe very quickly.
What to mention before a dose
Tell your healthcare professional if you have ever had a serious allergic reaction to a previous dose of this vaccine or to any of its ingredients.
Tell your healthcare professional if you have a bleeding disorder, take blood-thinning medicine, or bruise easily.
Tell your healthcare professional if you have a weakened immune system or take medicine that affects your immune system, or if you have a condition affecting your body's complement system.
Tell your healthcare professional if you have fainted during a previous injection or blood test.
If you are feeling unwell with a fever on the day of your appointment, ask your healthcare professional whether vaccination should be postponed.
How it is given
Your healthcare professional will give you this vaccine as a needle (injection) into the muscle of your upper arm.
If you are getting more than one vaccine on the same day, each one will be given as a separate needle in a different spot.
Important things to know
As with any injected vaccine, a serious allergic reaction is possible, though rare. Your healthcare provider will have treatment available in case this happens.
Some people feel faint or lightheaded after getting a needle. You may be asked to sit or lie down for a short time after your injection.
If you have certain immune system conditions, this vaccine may not protect you as well, even if you develop antibodies — talk to your healthcare professional about your specific risk.
Effects you may notice
Pain, redness, or swelling where the needle was given.
Feeling tired.
Headache.
Muscle aches or joint pain.
Chills or a mild fever.
Nausea, vomiting, or diarrhea.
When to contact a healthcare professional
Redness, swelling, or pain at the injection site gets worse or does not improve after a few days.
You develop a high fever.
You have any concerns about a reaction after your vaccination.
When to get emergency help
Swelling of the face, lips, tongue, or throat, or sudden difficulty breathing.
A widespread rash or hives that appear soon after vaccination.
Fainting that does not quickly resolve, or a fall that causes injury.
Other medicines and vaccines
This vaccine can be given at the same time as certain other vaccines, such as HPV or Tdap, but each one will be given as a separate needle in a different spot.
Tell your healthcare professional about all medicines you take, especially blood thinners or medicines that affect your immune system.
Key points to remember
Keep a record of your vaccination dates in case you need proof of immunization later, such as for school or travel.
Tell any future healthcare provider that you have received this vaccine.
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination. Public health recommendations may differ from a product monograph's authorized schedule.
Meningococcal B (TRUMENBA) — 10 years and older, two doses
2 doses
Two doses 6 months apart for people 10 years and older who are not at high risk.
TRUMENBA is authorized for 10 years of age and older. Routine two-dose schedule at 0 and 6 months. High-risk people need the three-dose schedule instead.
Meningococcal B (TRUMENBA) — high-risk conditions, three doses
3 doses
Three doses at 0, 1 to 2 and 6 months for high-risk people 10 years and older.
For asplenia, complement deficiency, HIV and other high-risk conditions from 10 years of age. Dose 2 at least 4 weeks after dose 1; dose 3 at least 4 months after dose 2 and at least 6 months after dose 1.
General information only. A suggested date is not an appointment or a prescription; a healthcare professional confirms what you need. Clinical rules reviewed on 2026-09-27.